994
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Nonalcoholic fatty liver disease is associated with early left ventricular diastolic dysfunction in patients with type 2 diabeteS

, , , &
Pages 117-124 | Received 30 Jun 2022, Accepted 29 Sep 2022, Published online: 25 Oct 2022

References

  • Lee BW, Lee YH, Park CY, et al. Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a position statement of the fatty liver research group of the Korean diabetes association. Diabetes Metab J. 2020;44(3):382–401.
  • Vanjiappan S, Hamide A, Ananthakrishnan R, et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease. Diabetes Metab Syndr. 2018;12(4):479–482.
  • Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–2224.
  • Tana C, Ballestri S, Ricci F, et al. Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications. Int J Environ Res Public Health. 2019;16(17):3104.
  • Gholoobi A, Gifani M, Gholoobi A, et al. Relationship between the prevalence and severity of non-alcoholic fatty liver disease and coronary artery disease: findings from a cross-sectional study of a referral center in northeast Iran. JGH Open. 2022;6(5):330–337.
  • Jaruvongvanich V, Chenbhanich J, Sanguankeo A, et al. Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(9):e28–e35.
  • Marwick TH, Ritchie R, Shaw JE, et al. Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol. 2018;71(3):339–351.
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–s33.
  • Paul J. Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult. Egypt Liver J. 2020;10(1):37.
  • Othman F, Abushahba G, Salustri A. Adherence to the American society of echocardiography and European association of cardiovascular imaging recommendations for the evaluation of left ventricular diastolic function by echocardiography: a quality improvement project. J Am Soc Echocardiogr. 2019;32(12):1619–1621.
  • Dong Y, Huang D, Sun L, et al. Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease using three-dimensional speckle-tracking echocardiography. Anatol J Cardiol. 2020;23(1):41.
  • Mauermann E, Bouchez S, Bove T, et al. Assessing left ventricular early diastolic velocities with tissue doppler and speckle tracking by transesophageal and transthoracic echocardiography. Anesth Analg. 2021;132(5):1400–1409.
  • Stahlschmidt FL, Tafarel JR, Menini-Stahlschmidt CM, et al. Hepatorenal index for grading liver steatosis with concomitant fibrosis. PLoS One. 2021;16(2):e0246837.
  • VanWagner LB, Wilcox JE, Ning H, et al. Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: the CARDIA study. J Am Heart Assoc. 2020;9(4):e014279.
  • Yamazaki H, Tsuboya T, Tsuji K, et al. Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes. Diabetes Care. 2015;38(9):1673–1679.
  • Saluja M, Kumar K, Swami YK, et al. Association between non- alcoholic fatty liver disease and left ventricular diastolic dysfunction in patients of type 2 diabetes. J Assoc Physicians India. 2019;67(8):20–24.
  • Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care. 2012;35(2):389–395.
  • Mantovani A, Pernigo M, Bergamini C, et al. Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes. PLoS One. 2015;10(8):e0135329.
  • Lee H, Kim G, Choi YJ, et al. Association between non-alcoholic steatohepatitis and left ventricular diastolic dysfunction in type 2 diabetes mellitus. Diabetes Metab J. 2020;44(2):267–276.
  • Petta S, Argano C, Colomba D, et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol. 2015;62(4):928–933.
  • Byrne CD, Targher G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014;34(6):1155–1161.
  • Lim S, Meigs JB. Ectopic fat and cardiometabolic and vascular risk. Int J Cardiol. 2013;169(3):166–176.
  • Nikolajević Starčević J, Janić M, Molecular Mechanisms ŠM. Responsible for diastolic dysfunction in diabetes mellitus patients. Int J Mol Sci. 2019;20(5):1197.
  • Salah HM, Pandey A, Soloveva A, et al. Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction. JACC Basic Transl Sci. 2021;6(11):918–932.